References
- JohnsonLStrickerRBTreatment of Lyme disease: A medicolegal assessmentExpert Rev Anti Infect Ther2004253355715482219
- HarveyWTSalvatoP‘Lyme disease’: Ancient engine of an unrecognized borreliosis pandemic?Med Hypotheses20036074275912710914
- StrickerRBJohnsonLLyme disease diagnosis and treatment: Lessons from the AIDS epidemicMinerva Med201010141942521196901
- StrickerRBJohnsonLLyme disease: The next decadeInfect Drug Resist201141921694904
- CameronDGaitoAHarrisNEvidence-based guidelines for the management of Lyme diseaseExpert Rev Anti Infect Ther200421 SupplS1S1315581390
- WormserGPDattwylerRJShapiroEDThe clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of AmericaClin Infect Dis2006411089113417029130
- EttestadPJCampbellGLWelbelSFBiliary complications in the treatment of unsubstantiated Lyme diseaseJ Infect Dis19951713563617844372
- ReidMCSchoenRTEvansJRosenbergJCHorwitzRIThe consequences of overdiagnosis and overtreatment of Lyme disease: An observational studyAnn Intern Med19981283543629490595
- PatelRGroggKLEdwardsWDWrightAJSchwenkNMDeath from inappropriate therapy for Lyme diseaseClin Infect Dis2000311107110911049799
- HolzbauerSMKempermanMMLynfieldRDeath due to community- associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected Lyme diseaseClin Infect Dis20105136937020597684
- StrickerRBGreenCLSavelyVRChamallasSNJohnsonLSafety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme diseaseMinerva Med20101011720228716
- FallonBANieldsJALyme disease: A neuropsychiatric illnessAm J Psychiatry1994151157115837943444
- FallonBAKeilpJGCorberaKMA randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathyNeurology200870992100317928580
- ScelsaSNLiptonRBSanderHHerskovitzSHeadache characteristics in hospitalized patients with Lyme diseaseHeadache1995351251307721571
- VennemanNGvan ErpecumKJGallstone disease: Primary and secondary preventionBest Pract Res Clin Gastroenterol2006201063107317127188
- McFarlandLVMeta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile diseaseAm J Gastroenterol200610181282216635227
- GibbonsRDHedekerDDuToitSAdvances in analysis of longitudinal dataAnnu Rev Clin Psychol201067910720192796
- BozdoganHAkaike’s information criterion and recent developments in information complexityJ Math Psychol200044629110733858
- StrickerRBCounterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme diseaseClin Infect Dis20074514915717578772
- StrickerRBJohnsonLGender bias in chronic Lyme diseaseJ Womens Health (Larchmt)2009181717171819857097
- KlempnerMSHuLTEvansJTwo controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme diseaseN Engl J Med2001345859211450676
- KruppLBHymanLGGrimsonRStudy and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trialNeurology2003601923193012821734
- OksiJNikoskelainenJHiekkanenHDuration of antibiotic treatment in disseminated Lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical studyEur J Clin Microbiol Infect Dis20072657158117587070
- StrickerRBJohnsonLPersistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alphaJ Infect Dis20081971352135318422450
- HodzicEFengSHoldenKFreetKJBartholdSWPersistence of Borrelia burgdorferi following antibiotic treatment in miceAntimicrob Agents Chemother2008521728173618316520
- BartholdSWHodzicEImaiDMFengSYangXLuftBJIneffectiveness of tigecycline against persistent Borrelia burgdorferiAntimicrob Agents Chemother20105464365119995919
- StrickerRBJohnsonLSearching for autoimmunity in “antibioticrefractory” Lyme arthritisMol Immunol2008453023302418395260
- TunevSSHasteyCJHodzicEFengSBartholdSWBaumgarthNLymphoadenopathy during Lyme borreliosis is caused by spirochete migration-induced specific B cell activationPLoS Pathog20117e100206621637808
- SapiEKaurNAnyanwuSEvaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferiInfect Drug Resist201149711321753890
- SmallPMFujiwaraPIManagement of tuberculosis in the United StatesN Engl J Med200134518920011463015
- BodurHErbayAColpanAAkinciEBrucellar spondylitisRheumatol Int20042422122612879273
- GarnerJPMacdonaldMKumarPKAbdominal actinomycosisInt J Surg2007544144818078685
- FreemanHJTropheryma whipplei infectionWorld J Gastroenterol2009152078208019418579
- LiuYHWangXGGaoJSQingyaoYHortonJContinuous albenda-zole therapy in alveolar echinococcosis: Long-term follow-up observation of 20 casesTrans R Soc Trop Med Hyg200910376877819457528
- LazzariniLLipskyBAMaderJTAntibiotic treatment of osteomyelitis: What have we learned from 30 years of clinical trials?Int J Infect Dis2005912713815840453
- PriceVEBlanchetteVSFord-JonesELThe prevention and management of infections in children with asplenia or hypospleniaInfect Dis Clin North Am200721697710viiiix17826619
- BeytoutJTournilhacOLaurichesseHAntibiotic prophylaxis in splenectomized adultsPresse Med20033228 SupplS1719 French14631641
- VosRVanaudenaerdeBMVerledenSEVan RaemdonckDEDupontLJVerledenGMAzithromycin in posttransplant bronchiolitis obliterans syndromeChest20111391246124721540223